# A Non-interventional Trial of Erlotinib (Tarceva) Metastatic Non-small Cell Lung Cancer

> **NCT02595450** · — · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 299 (actual)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

- **DRUG:** Erlotinib

## Key facts

- **NCT ID:** NCT02595450
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 299 (ACTUAL)
- **Last updated:** 2016-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02595450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02595450, "A Non-interventional Trial of Erlotinib (Tarceva) Metastatic Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02595450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*